These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9085341)

  • 1. Acute management of ventricular arrhythmias: role of antiarrhythmic agents.
    Singh BN
    Pharmacotherapy; 1997; 17(2 Pt 2):56S-64S; discussion 89S-91S. PubMed ID: 9085341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arrhythmias during pregnancy].
    Trappe HJ
    Dtsch Med Wochenschr; 2008 Sep; 133(36):1799-804. PubMed ID: 18767007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmias in the intensive care patient.
    Trappe HJ; Brandts B; Weismueller P
    Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac arrhythmias in pregnancy].
    Trappe HJ; Pfitzner P
    Z Kardiol; 2001; 90 Suppl 4():36-44. PubMed ID: 11373942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of antiarrhythmic drug management of electrical storm.
    Kowey PR
    Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of newer antiarrhythmic drugs in the management of patients with ventricular arrhythmias.
    Cain ME
    Angiology; 1988 Jul; 39(7 Pt 2):668-83. PubMed ID: 3044200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H; Hindricks G; Kottkamp H
    Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute treatment of stable hemodynamically tolerable ventricular tachycardia].
    Haverkamp W; Rolf S; Stockburger M; Dietz R
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):207-12. PubMed ID: 15832239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
    Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
    Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced cardiac life support controversy: where do antiarrhythmic agents fit in?
    Chow MS
    Pharmacotherapy; 1997; 17(2 Pt 2):84S-88S; discussion 89S-91S. PubMed ID: 9085344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac arrhythmias during pregnancy--what to do?].
    Trappe HJ
    Herz; 2003 May; 28(3):216-26. PubMed ID: 12756479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should amiodarone or lidocaine be given to patients who arrest after cardiac surgery and fail to cardiovert from ventricular fibrillation?
    Leeuwenburgh BP; Versteegh MI; Maas JJ; Dunning J
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1148-51. PubMed ID: 18796471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
    Long B; Koyfman A
    J Emerg Med; 2017 Apr; 52(4):484-492. PubMed ID: 27751700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class III antiarrhythmic agents: the next wave.
    Bauman JL
    Pharmacotherapy; 1997; 17(2 Pt 2):76S-83S; discussion 89S-91S. PubMed ID: 9085343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone in the prevention and treatment of arrhythmia.
    Auer J; Berent R; Eber B
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1037-44. PubMed ID: 12186264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
    Marill KA; deSouza IS; Nishijima DK; Senecal EL; Setnik GS; Stair TO; Ruskin JN; Ellinor PT
    Acad Emerg Med; 2010 Mar; 17(3):297-306. PubMed ID: 20370763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful management of ventricular fibrillation and ventricular tachycardia using defibrillation and intravenous amiodarone therapy in a cat.
    Berlin N; Ohad DG; Maiorkis I; Kelmer E
    J Vet Emerg Crit Care (San Antonio); 2020 Jul; 30(4):474-480. PubMed ID: 32400960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.